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Ethnopharmacological relevance: The leaves of Pereskia aculeata Miller (Cactaceae), known as Barbados
gooseberry, are used in Brazilian traditional medicine as emollients and to treat skin wounds and in-
ﬂammation. This study investigated the topical anti-inﬂammatory activity of the hexane fraction (HF)
obtained from the methanol extract of the leaves of this species in models of acute and chronic ear
dermatitis in mice.
Material and methods: Mice ear edema was induced by topical application of croton oil, arachidonic
acid, capsaicin, ethyl-phenylpropiolate and phenol; and by subcutaneous injection of histamine. Ear
biopsies were obtained to determine the levels of IL-1β, IL-6 and TNF-α cytokines by ELISA assay. His-
topathological analysis was also performed to evaluate the HF activity in croton oil multiple application
test. In addition, acute dermal irritation/corrosion test in rats was accomplished. HF chemical char-
acterization was performed by GC–MS analysis.
Results: HF intensively reduced the inﬂammatory process induced by all irritant agents used, except
for arachidonic acid. This activity is related, at least in part, to the reduction of IL-6 and TNF-α cytokines
levels. Moreover, when the glucocorticoid receptor antagonist mifepristone was used, HF failed to re-
spond to the croton oil application.The results strongly suggested a glucocorticoid-like effect, which was
reinforced by the presence of considerable amounts of sterol compounds identiﬁed in HF. The acute
dermal irritaton/corrosion test showed no signs of toxicity.
Conclusions: This study showed that the acute and chronic anti-inﬂammatory activity of P. aculeata
leaves is very promising, and corroborates to better understand their ethnopharmacological applications.
& 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The skin, the largest organ of the human body, plays an es-
sential role as a protective barrier against microorganisms, andrved.chemical and physical injuries from the external environment.
This physiological barrier consists of a complex network of struc-
tural, cellular and molecular components which provide an ef-
fective defensive immunological reaction against harmful stimuli
(Nestle et al., 2009; Bangert et al., 2011). Nevertheless, in some
circumstances, alterations in the skin immunological balance may
elicit inappropriate defensive responses which lead to an
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iasis, eczema, atopic dermatitis and allergic contact dermatitis (Lee
and Hwang, 2012). The current therapeutic agents available to
treat skin inﬂammation are mainly glucocorticoids, which often
exhibit adverse reactions that affect the hypothalamic–pituitary
axis, the lipids, carbohydrates, proteins and bone metabolisms,
and the organs related to the immune system (Poetker and Reh,
2010; Sarnes et al., 2011; Rang et al., 2012).
In this context, plant extracts and natural substances remain as
an alternative in the search for new safer and more effective to-
pical anti-inﬂammatory drugs (Newman and Cragg, 2012). There
are reports that leaves of Pereskia aculeata Miller (Cactaceae),
known as Barbados gooseberry, are used in folk medicine as
emollients and to treat skin wounds and inﬂammatory process
(Duarte and Hayashi, 2005; Sartor et al., 2010; Pinto and Scio,
2014). P. aculeata is a climbing cactus shrub distributed in Central
and South America, covering mainly from south to northeast of
Brazil, where its leaves are also used by natives as a vegetable in
traditional cuisine (Takeiti et al., 2009; Rosa and Souza, 2003;
Paterson et al., 2009). However, there are only few studies about P.
aculeata leaves phytochemicals and their therapeutic potential
(Pinto et al., 2012; Pinto and Scio, 2014). Recently, Carvalho et al.
(2014) reported the in vitrowound healing activity of the mucilage
extracted from the leaves of this species, and Pinto et al. (2015)
showed that the hydromethanolic fraction from the crude extract
of the leaves presented central and peripheral antinociceptive
activity in mice.
Preliminary studies performed by our group showed that,
among the different fractions obtained from the methanol extract
of P. aculeata leaves by solvent partition, the hexane fraction
showed the most remarkable anti-inﬂammatory potential (data
not shown).
For that reason, in order to contribute to the search for new
plant extracts or natural substances with anti-inﬂammatory po-
tential, and for better understanding the ethnopharmacological
relevance of P. aculeata, this study was conducted to further in-
vestigate the topical anti-inﬂammatory activity of the hexane
fraction (HF) obtained from the methanol crude extract of the
leaves of this species in models of acute and chronic ear dermatitis
in mice, using different phlogistic agents. In addition, an estab-
lished acute dermal irritation and corrosion test in rats was ac-
complished to predict a possible dermal toxicity of HF. Chemical
characterization of HF was also performed.2. Materials and methods
2.1. Plant material
The plant material was collected in Juiz de Fora (MG, Brazil) in
August 2010, in the morning. A voucher specimen (No. 57539) was
deposited in the Herbarium Leopoldo Krieger of the Federal Uni-
versity of Juiz de Fora for future evidence.
The leaves were air-dried in a well-ventilated place at room
temperature (25 °C) for 15 days. Once dried, the material (ap-
proximately 1 kg) was powdered using a knife mill and then ex-
tracted by maceration with methanol until exhaustion. The extract
was concentrated on a rotary evaporator to obtain the crude me-
thanol extract (140 g), which was dissolved in methanol/water
(8:2 v/v) and then fractionated with hexane by solvent partition.
The hexane fraction (38 g) was stored in a refrigerator at 4 °C.
2.2. Chemicals
Croton oil, arachidonic acid (AA), capsaicin, ethyl-phenylpro-
piolate (EPP), phenol, histamine, indomethacin, dexamethasone,mifepristone, bovine serum albumin (BSA), phenylmethylsulpho-
nyl ﬂuoride (PMSF), benzethonium chloride, ethylenediaminete-
tracetic acid (EDTA) and aprotinin were purchased from
Sigma-Aldrich
s
(St. Louis, MO, USA). Ketamine chloride and xyla-
zine chloride were obtained from Syntec
s
(Hortolândia, SP, Brazil).
Animal commercial chow was from Nuvitalis
s
(Colombo, PR, Bra-
zil). All other reagents were of the highest quality available.
2.3. Pharmacological assays
2.3.1. Animals
Male Swiss mice (20–30 g) and Male Wistar rats (160–200 g)
bred in the Center of Reproductive Biology (Federal University of
Juiz de Fora, Brazil) were used. The animals were kept under
standard temperature (22 °C), 12/12 h light/dark cycle, and had
food and water ad libitum. The groups consisted of 6–8 animals. All
experimental procedures are in accordance with the Ethical Prin-
ciples of Animal Research adopted by Brazilian College of Animal
Experimentation (COBEA – Protocols no 013/2013, 021/2013, 016/
2013 and 028/2014).
2.3.2. Topical anti-inﬂammatory activity on acute inﬂammation
2.3.2.1. Croton oil single application-induced ear edema test. This
test was carried out in accordance to the method described by
Schiantarelli et al. (1982). Each mouse was immobilized by hands,
and 20 mL of a fresh solution of croton oil 2.5% (v/v) were topically
applied on the inner surface of the right ear and the same volume
of acetone (vehicle) on the inner surface of the left ear. Im-
mediately after the application of the phlogistic agent, the animals
received topical treatment with 20 mL of HF (0.1, 0.5, and 1.0 mg/
ear), dexamethasone (reference drug) 0.1 mg/ear, or acetone. Four
hours after the topical applications, the animals were euthanized
and 6 mm diameter ear punch biopsies were collected and sub-
jected to ear edema measurement. Subsequently, the fragments
obtained from the right ears of dexamethasone, vehicle and HF
1.0 mg/ear groups were stored at 80 °C in order to measure in-
terleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and inter-
leukin-6 (IL-6) cytokines levels.
2.3.2.2. AA, EPP, capsaicin and phenol-induced ear edema tests. Each
mouse was immobilized by hands. Then, 20 mL of fresh solutions of
AA 2.0 mg/ear (Young et al., 1984), EPP 1.0 mg/ear (Giner et al.,
2000), capsaicin 1.0 mg/mL (Gábor and Razga, 1992), or phenol
10% (v/v) (Gábor, 2000) were topically applied on the inner surface
of the right ear, and 20 mL of acetone (vehicle) on the inner surface
of the left ear. Immediately after the application of the phlogistic
agents, the animals received topical treatment with 20 mL of HF
1.0 mg/ear, indomethacin 0.5 mg/ear (reference drug for AA test),
dexamethasone 0.1 mg/ear (reference drug for EPP, capsaicin and
phenol tests) or acetone. One hour after topical applications of AA,
EPP and phenol, and 30 min after topical application of capsaicin,
the animals were euthanized and 6 mm diameter ear punch
biopsies were subjected to ear edema measurement.
2.3.2.3. Histamine-induced ear edema test. The animals were trea-
ted topically with 20 mL of HF 1.0 mg/ear, dexamethasone 0.1 mg/
ear (reference drug) or acetone on the inner surface of the right
ear and the same volume of acetone on the inner surface of the left
ear. After 20 min, mice were anesthetized by intraperitoneal ap-
plication of ketamine 80 mg/kg and xylazine 15 mg/kg. Thirty
minutes after the topical treatments, 10 mL of histamine dihy-
drochloride 0.1 mg/mL diluted in NaCl 0.9% were applied sub-
cutaneously with a 29-G needle syringe in the right ear of each
mouse, whereas only NaCl 0.9% was injected in the left ear. Two
hours after the treatments applications, the animals were eu-
thanized and 6 mm diameter ear punch biopsies were collected for
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2.3.2.4. IL-1β, TNF-α and IL-6 levels determination. The ear biopsies
obtained from the croton oil test were used to evaluate the HF
ability to inﬂuence the IL-1β, TNF-α and IL-6 cytokines levels. The
ears were homogenized in 800 mL of extraction buffer (BSA 0.5%,
PMSF 0.1 M, benzethonium chloride 0.1 M, EDTA 10 mM, and
aprotinin 20 kIU/ml) and centrifuged at 10,000 rpm for 15 min at
4 °C. The supernatants were stored and used to measure the cy-
tokine levels using commercial ELISA kits (R&D Systems, Min-
neapolis, MN, USA) according to the procedures supplied by the
manufacturer. The levels of the cytokines were determined in
duplicate by an ELISA reader at 450 nm.
2.3.2.5. Croton oil single application-induced ear edema test after
glucocorticoid antagonism. To verify whether HF mechanism of
action is glucocorticod-like, the croton oil single application-in-
duced ear edema test was accomplished as previously described
(Section 2.3.2.1) 15 min after subcutaneous injection of mifepris-
tone, an glucocorticoid antagonist, diluted in polyethylene glycol
400 (PEG 400), at 50 mg/kg, 100 mL (Horinouchi et al., 2013). An-
imals were treated with vehicle (acetone), HF 1.0 mg/ear, dex-
amethasone 0.1 mg/ear or indomethacin 0.5 mg/ear.
2.3.2.6. Ear edema measurement and statistical analysis. The ear
punch biopsies were individually weighed using an analytical
balance. The weight difference between the inﬂamed right ear and
the non-inﬂamed left ear of each mouse indicated the intensity of
the edema. All results were expressed as mean7S.E.M. One-way
ANOVA followed by Newman–Keuls test was applied for statistical
analysis using the software GraphPad Prism
s
5.0. po0.05 was
considered signiﬁcant.
2.3.3. Topical anti-inﬂammatory activity on chronic inﬂammation
2.3.3.1. Croton oil multiple application-induced ear edema test. This
test was carried out for 10 consecutive days (days 0–9) as de-
scribed by Stanley et al. (1991) with minor modiﬁcations. On the
day 0, each mouse was anesthetized by intraperitoneal application
of ketamine 80 mg/kg and xylazine 15 mg/kg for the measurement
of the natural ear thickness of the right ear using a digital mi-
crometer. On the day 1, 20 mL of a fresh croton oil 2.5% (v/v) so-
lution were topically applied on the inner surface of the right ear.
This same procedure was conducted on alternate days. The ani-
mals were treated with 20 mL HF 1.0 mg/ear, dexamethasone
0.1 mg/ear and acetone (vehicle) twice a day, between days 5 and
9. The ear thickness was measured on alternate days (days 1, 3, 5,
7 and 9). On the day 9, animals were euthanized and 6 mm dia-
meter ear punch biopsies were collected for edema measurement
as previously described (Section 2.3.2.6) and for histopathological
analysis. The results were expressed as mean7S.E.M, and two-
way ANOVA followed by Bonferroni test was applied using the
software GraphPad Prism
s
5.0 for statistical analyses. po0.05 was
considered signiﬁcant.
2.3.3.2. Histopathological analysis. Ear biopsies were ﬁxed in 70%
ethanol for 24 h and then preserved in 10% formalin. Subsequently,
the ears were dehydrated, blocked in parafﬁn, and transversely
sectioned with a microtome (4 mm). The cross-sections were
stained with hematoxylin and eosin for the evaluation of edema
intensity, vasodilation and leukocyte inﬁltration. Representative
areas were selected for qualitative light microscopic analysis.
Images were captured using the Image-Pro Plus
s
6.0 software (40,
100 and 400 magniﬁcation).
2.3.4. Acute dermal irritation/corrosion test
The acute dermal irritation/corrosion test for HF was conductedas recommended by the OECD Guideline 404 (2002) in rats. The
animals were anesthetized with ketamine 90 mg/kg and xylazine
10 mg/kg intraperitoneally and the dorsocostal area was shaved.
The next day, animals with intact skin (n¼3) received 0.5 g of HF
without any dilution, which was applied uniformly on a small
shaved region (3 cm2). The area was covered with gauze and a
hypoallergenic tape. HF was maintained in contact with the skin
for 4 h, and then removed. After 1, 24, 48 and 72 h all animals were
examined for signs of erythema, edema, dry skin and any local or
systemic clinical adverse effects, including body weight and water
and food consumption, which were evaluated daily for 14 days.
Distilled water was used as negative control.
2.4. Phytochemical characterization by GC–MS analysis
The phytochemical characterization of HF was performed by
gas chromatography–mass spectrometry (GC–MS) analysis using
Agilent Technologies GC Hewlett Packard 6890 and MS Hewlett
Packard P 5972 devices. An analytical DB-5MS capillary column
(30 m length0.25 mm inner diameter; 0.25 mm ﬁlm thickness)
was connected to the system. Helium was used as the carrier gas
with a ﬂow rate adjusted to 0.5 ml/min. The oven temperature was
programmed as a gradient from 50 °C to 300 °C for 50 min, and an
isotherm at 300 °C was maintained for more 15 min, so that the
total run time used was 65 min. The injector temperature was set
to 270 °C. The mass spectrometer operated by electron impact
(70 eV) with the ion source at 230 °C. The individual compounds
were identiﬁed by mass spectra comparison using the mass
spectrometer library database (WILEY 275.1).3. Results
3.1. Topical anti-inﬂammatory activity on acute inﬂammation
In croton oil-induced ear edema test HF, at all the doses tested,
showed expressive activity, however the dose of 1.0 mg/ear was
the most effective, inhibiting the edema formation by 75%
(Fig. 1A). Nevertheless, HF did not show any action in AA challenge
test (Fig. 1B). As shown in Fig. 1C–F, HF efﬁciently inhibited the
EPP, capsaicin, phenol and histamine-induced ear edema by 45%,
46%, 82% and 55%, respectively.
As shown in Fig. 2, HF reduced signiﬁcantly the IL-6 and TNF-α
levels in ear biopsies obtained from the croton oil single applica-
tion test, in a manner similar to dexamethasone. On the other
hand, the levels of IL-1β were similar to the vehicle group.
HF and dexamethasone did not respond to the croton oil topical
application after the pretreatment with mifepristone, a gluco-
corticoid receptors inhibitor, as shown in Fig. 3.
3.2. Topical anti-inﬂammatory activity on chronic inﬂammation
As shown in Fig. 4, HF and dexamethasone showed similar
activity in the croton oil-induced ear edema multiple application
test. The histopathological analysis emphasized that HF inhibited
the edema considerably (Fig. 5A–C). Leukocytes inﬁltration
(Fig. 5G–I) and vasodilation (Fig. 5D) were also less intense in HF
group.
3.3. Acute dermal irritation/corrosion test
The rats subjected to topical application of HF in the acute
dermal irritation/corrosion test showed no clinical signs of local or
systemic toxicity.
Fig. 1. Effect of HF in mice ear edema induced by different phlogistic agents. (A) croton oil single application; (B) AA; (C) EPP; (D) capsaicin; (E) phenol; (F) histamine. HF at
0.1, 0.5 and 1.0 mg/ear was used in croton oil single application test, and HF at 1.0 mg/ear was used in further studies. Dexamethasone (Dexa) or indomethacin (Indo) were
used as reference drugs at 0.1 and 0.5 mg/ear, respectively. Values in each column represent the mean7S.E.M. of the weight difference between right and lefts ears. One-way
ANOVA followed by Newman–Keuls test was used for statistical analysis. Signiﬁcant values: *po0.05, **po0.01, and ***po0.001 vs vehicle.
Fig. 2. Effect of HF 1.0 mg/ear on cytokines levels in ear biopsies obtained from croton oil single application test. (A) IL-1β; (B) TNF-α; (C) IL-6. Values in each column
represent the mean7S.E.M. One-way ANOVA followed by Newman–Keuls test was used for statistical analysis. Signiﬁcant values: *po0.05, and ***po0.001 vs vehicle.
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Fig. 3. Effect of HF in mice ear edema induced by croton oil after pretreatment with
mifepristone. HF, dexamethasone (Dexa) and indomethacin (Indo) at 1.0, 0.1 and
0.5 mg/ear, respectively, was topically applied. Mifepristone 50 mg/kg was sub-
cutaneously injected 15 min before croton oil single application. Values in each
column represent the mean7S.E.M. of the weight difference between right and
lefts ears. One-way ANOVA followed by Newman–Keuls test was used for statistical
analysis. Signiﬁcant values: *po0.05 vs vehicle.
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The GC–MS chemical analysis of HF showed considerable
amounts of phytosterols, including campesterol, stigmasterol and
sitosterol (Table 1).4. Discussion
The mice ear edema is an appropriate animal model for the
evaluation of topical anti-inﬂammatory activity of plant-related
compounds as it is rapidly accomplished, provides reproducible
results and requires a small amount of the natural substances,
which obtainment is, in some cases, time-consuming and ex-
pensive (Gábor, 2003).
The main irritant constituent in croton oil, 12-o-tetra-
canoilphorbol-13-acetate (TPA), is an activator of the protein ki-
nase C (PKC) and the mitogen-activated protein kinases (MAPK),
which stimulate the release of transcription factors, such as the
nuclear factor κB (NF-κB) and the activating protein-1 (AP-1),
which are essential for the activation of pro-inﬂammatory cyto-
kines, including IL-1β, TNF-α and IL-6, and other mediators, such
as phospholipase-A2, (PLA2), platelet activating factor (PAF) and
arachidonic acid (AA). These mechanisms increase the vascular
permeability, vasodilation, leukocyte migration, release of hista-
mine and serotonin, and the levels of eicosanoids synthesized by
cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) enzymes
(Pascual and Glass, 2006; Saraiva et al., 2011). As several different
inﬂammatory pathways are stimulated by croton oil, anti-Fig. 4. Effect of HF 1.0 mg/ear in mice ear edema induced by croton oil multiple applicat
response curve on ear thickness during 10 consecutive days; the arrows indicate the day
ears thickness were measured; the values represent the mean7S.E.M of ear thickness; t
on the last day; values in each column represent the mean7S.E.M of the weight differe
was used for statistical analysis. Signiﬁcant values: *po0.05, and ***po0.001 vs vehiclinﬂammatory drugs with distinct mechanisms of action may re-
spond effectively to this model (Murakawa et al., 2006; Garg et al.,
2008). For this reason, this phlogistic agent was used in this study
to identify HF anti-inﬂammatory activity and to evaluate its dose–
response using three different doses. The dose of 1.0 mg/ear was
the most effective (Fig. 1A) and, for that reason, it was used in the
further tests to better understand HF anti-inﬂammatory action.
AA, as an inductor of skin inﬂammation, stimulates the eico-
sanoids production, including PGE2 and leukotrienes, which are
synthesized by COX and 5- LOX enzymes respectively, and induces
a rapid and intense inﬂammatory response. Therefore, AA is often
used to identify compounds capable to suppress the eicosanoids
synthesis, as indomethacin, a COX inhibitor (Carlson et al., 1985;
Crummey et al., 1987; Gábor, 2000). As HF clearly did not respond
to this test (Fig. 1B), it can be concluded that its anti-inﬂammatory
mechanism is not related to the AA metabolism, which en-
couraged further studies to better understand its action. EPP to-
pical application induces an inﬂammatory process by AA pathway;
however this phlogistic agent also elicits the release of histamine,
serotonin and bradykinin relevantly, activating mainly a vascular
response (Brattsand et al., 1982; Just et al., 1998). As shown in
Fig. 1C, HF inhibited the EPP-induced edema formation, which
suggested that HF may have inﬂuence in EPP pro-inﬂammatory
mediators, including histamine. For this reason, histamine was
also used as an irritant agent in this study.
Histamine is an endogenous vasoactive amine which is re-
leased by mast cell degranulation and increases vasodilation and
vascular permeability in the course of the inﬂammatory process,
leading to plasma extravasation, erythema and nerve ﬁbers sen-
sitization. In addition, histamine regulates the release of several
cytokines, including IL-1β, TNF-α and IL-6 (Brand et al., 2002;
O'Mahoni et al., 2011). Antihistaminergic and glucocorticoids
drugs are frequently effective to reduce histamine-induced edema
(Saraiva et al., 2011). As shown in Fig. 1F, HF was efﬁcient in the
histamine challenge test.
Capsaicin is the chemical constituent responsible for the pun-
gency of peppers of the genus Capsicum. This substance has the
ability to activate the transient receptor potential vanilloid type 1
(TRPV1), an ion channel expressed in sensory neurons. TRPV1
activation induces the release of neuropeptides, including sub-
stance P and tachykinin, and monoamines, such as serotonin and
histamine. Those mechanisms lead to an increase in edema for-
mation, blood ﬂow and leukocytes recruitment (Szolcsányi, 2004;
Zegarska et al., 2006; Alawi and Keeble, 2010). Thus, capsaicin-
induced ear edema model is adequate to identify compounds
capable to inhibit a neurogenic inﬂammatory process, which is
caused by a nociceptive stimulus (Alawi and Keeble, 2010). As
shown in Fig. 1D, HF reduced efﬁciently the capsaicin edemaion test. Dexamethasone (Dexa) at 0.1 mg/ear was used as reference drug. (A) time–
s in which the animals were treated, and the circles indicate the days in which the
wo-way ANOVA followed by Newman–Keuls test was used; (B) effect on ear weight
nce between right and lefts ears; one-way ANOVA followed by Newman–Keuls test
e.
Fig. 5. Representative photomicrographs of transverse sections of mice ear biopsies obtained from the croton oil multiple application ear edema test on the day 9 (40, 100
and 400 magniﬁcation; H&E staining). (A) vehicle 40 ; (B) dexamethasone 0.1 mg/ear 40 ; (C) HF 1.0 mg/ear 40 ; (D) vehicle 100 ; (E) dexamethasone 0.1 mg/ear
100 ; (F) HF 1.0 mg/ear 100 ; (G) vehicle 400 ; (H) dexamethasone 0.1 mg/ear 400 ; (I) HF 1.0 mg/ear 400 . In (A), (B) and (C), the double arrows indicate the edema
intensity; in (D) the arrows indicate intense vasodilation; in (G), (H) and (I) the arrows indicate the presence of inﬂammatory cells. Images were captured using the Image-
Pro Plus
s
6.0 software.
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effective in this test; however COX inhibitors are not capable to
respond (Inoue et al., 1993, 1995a, 1995b). Therefore, the results
for capsaicin test were important to identify the neurogenic anti-Table 1
Chemical constituents identiﬁed in HF by GC–MS analysis.
Retention time (min) Compound Molecular
9.199 Decane 142
10.714 4,5-Dimethyl-2,6-octadiene 138
12.041 Undecane 156
23.516 Nerolidol 222
26. 774 1-Methoxy-p-tolyl-propan-2-ol 181
30.499 Neophytadiene 278
32.308 Methyl palmitate 270
32.962 Palmitic acid 256
35.648 Linolenic acid methyl ester 292
35.821 Phytol 297
36.136 Methyl octadecanoate 298
39.186 Tricosane 324
51.290 Cholesterol 386
52.969 Campesterol 400
53.415 Stigmasterol 412
54.556 Sitosterol 414
55.117 Taraxerol 426
56.453 Taraxasterol 426
Total
The individual compounds were identiﬁed by mass spectra comparison using the massinﬂammatory potential of HF, and also to corroborate to the other
ﬁndings presented in this study, more particularly regarding to the
lack of HF activity in the AA challenge test.
The inﬂammatory reaction and tissue damage induced byweight Area (%) Main MS fragmentation ions
0.72 142-113, 85, 71, 57, 43
1.11 138-123, 95, 69, 41
0.53 156-127, 85, 71, 57, 43
0.70 222-204, 161, 93, 69, 41
6.81 181-144, 116, 103, 87, 73
1.19 278-123, 95, 68, 43
2.34 270-227, 143, 87, 74, 55, 43
0.89 256-213, 129, 73, 60, 43
1,62 292-108, 95, 79, 67, 55, 41
4.51 297-123, 95, 81, 71, 57, 43
0.44 298-143, 87, 74, 55, 43
0.81 324-113, 99, 85, 71, 57, 43
1.89 386-301, 275, 213, 145, 44
8.97 400-382, 367, 315, 289, 213, 145, 43
6.89 412-351, 271, 255, 159, 133, 83, 69, 55
24.66 414-396, 329, 303, 213, 145, 107, 81, 57, 43
7.12 426-302, 287, 204, 135, 95, 69
11.59 426-207, 189, 135, 95, 69, 43
84.25
spectrometer library database (WILEY 275.1).
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species (ROS) production and to the rupture of keratinocytes
membranes, which elicits the release of pro-inﬂammatory cyto-
kines, including IL-1α, IL-1β, IL-6, IL-8 and TNF-α (Wilmer et
al.,1994; Murray et al., 2007). Skin enzymes, such as COX-2, tyr-
osinase and LOX, generate a favorable microenvironment for oxi-
dation of the phenol molecule, so that phenol is an appropriate
irritant agent to simulate the contact dermatitis inﬂammation in
mice (Lim et al., 2004; Murray et al., 2007). Skin toxic phenolic
compounds are often used in resins, paints, varnishes and cos-
metic products. Consequently, industrial workers and consumers
are commonly exposed to these agents, which may cause several
disorders, including erythema, edema, burns, necrosis, skin de-
pigmentation and cancer (Murray et al., 2007). Thus, the use of
phenol induced-ear edema model is also relevant in the search for
topical anti-inﬂammatory drugs. HF showed expressive activity in
this test (Fig. 1E), which suggested its remarkable potential for the
treatment of contact dermatitis. This action may be related to the
antioxidant activity of P. aculeata leaves reported by Pinto et al.
(2012), and to the inhibition of pro-inﬂammatory cytokines.
Therefore, it was evaluated whether HF is capable to interfere
in cytokine levels in an inﬂamed tissue. As shown in Fig. 2, HF
reduced signiﬁcantly the IL-6 and TNF-α levels in ear biopsies
obtained from the croton oil single application test. However, the
levels of IL-1β were similar to the vehicle group, which is not
surprising, as this cytokine is closely related to the activation of
COX enzymes (Akira et al., 1990; Rider et al., 2011), and the results
presented in this study strongly suggested that HF did not inter-
fere in the AA metabolism.
The croton oil multiple application test is useful to assess a
drug response in chronic inﬂammatory process. Glucocorticoids
and 5-LPOX inhibitors respond efﬁciently to this test; however
COX inhibitors and antihistaminergic drugs are not effective
(Green and Shuster, 1987; Stanley et al., 1991). The results of this
test (Figs. 4 and 5), along with those obtained from the acute in-
ﬂammation models, strongly indicated that HF mechanism of ac-
tion was probably due to a glucocorticoid-like effect. To conﬁrm
this proposition, the croton oil single application test was re-
peated, however, at that time, the animals were pretreated with
mifepristone, a glucocorticoid antagonist (Horinouchi et al., 2013).
Once the glucocorticoid receptors were inhibited, HF and dex-
amethasone did not respond to the croton oil test, unlike in-
domethacin, which mechanism of action is related to COX in-
hibition (Fig. 3). This result conﬁrmed that, at least in part, HF anti-
inﬂammatory effect was due to glucocorticoid receptors activation.
HF showed no clinical signs of toxicity in the acute dermal ir-
ritation/corrosion test. It is noteworthy to mention that P. aculeata
leaves are commonly used as food in Brazilian traditional cuisine
and as a topical remedy in folk medicine, and there are no reports
of skin or systemic adverse effects.
The chemical analysis of HF showed considerable amounts of
phytosterols (Table 1). The chemical structure of those compounds
are very similar to glucocorticoids, which may suggest similar
biological actions (Dewick, 2009). In fact, phytosterols anti-in-
ﬂammatory activities are well described in literature. Their in-
gestion decreases plasma levels of pro-inﬂammatory components,
including C-reactive protein, phospholipase A1, IL-6, TNF-α, NF-kB
and other cytokines and transcription factors (Othman and Mo-
ghadasian 2011). In addition, many studies have reported the ef-
ﬁcacy of plant sterols as topical anti-inﬂammatory agents (Gómez
et al., 1999; Navarro et al., 2001; Medeiros et al., 2007; Puglia and
Bonina, 2008).
Taraxerol and taraxasterol are anti-inﬂammatory triterpenes
that were also identiﬁed in HF. These compounds have been iso-
lated from a variety of plants, and have shown the property of
decreasing the production of NO, PGE2, NF-kB, TNF-α, IL-6 and IL-1β in vitro (Zhang et al., 2012; Yao et al., 2013). Besides, Akihisa
et al. (1996) reported the anti-inﬂammatory activity of taraxerol
and taraxasterol in TPA-induced ear edema model in mice.
Phytol may also contribute to HF activity, as Silva et al. (2013)
recently reported that this diterpene was able to inhibit rats paw
edema, leukocyte migration, oxidative stress and IL-1β and TNF-α
cytokines.5. Conclusion
HF showed intense chronic and acute topical anti-inﬂammatory
activity against different irritant agents with no clinical signs of
toxicity. Its mechanism of action is related, at least in part, to the
inhibition of IL-6 and TNF-α cytokines. In addition, the pharma-
cological results strongly suggested a glucocorticoid-like effect,
which was reinforced by the presence of signiﬁcant amounts of
phytosterols. Taraxerol, taraxasterol and phytol may also con-
tribute to the HF activity. For this reason, future studies aimed to
evaluate typical adverse reaction related to glucocorticoids are
important. This study is the ﬁrst report on the anti-inﬂammatory
activity of P. aculeata leaves and corroborates to better understand
its ethnopharmacological applications.Acknowledgments
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